Scholars Central

Conference abstractPublished 7 Nov 2016

Seamless Technology Transfer Process (TTP) to CMOs

Authors: Adnan Sabir

Pharma Consulting Services, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Transferring the âÂ?Â?Risk BasedâÂ?Â?, ICH Q9 compliant, drug development and manufacture to CMOs can be subject to many pitfalls. I would like to share my experience of how we can make such Technology Transfer Process (TTP) effective, seamless and utilizing the latest regulatory, technical, practical and business tools. Considerations for preparing for the process transfer, ensuring logistics, quality based design principles, equipment and materials consistency, and posttransfer activities will be discussed; which are very crucial to the success. Key learning objectives will include: Understand the product transfer process from preparing the transfer, performing the transfer and what is required after the transfer; establish and review metrics (measurement/feedback tools) to determine product transfer success; and establish a solid Technical Quality Agreement (TQA).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Developing Drugs.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Developing Drugs
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Adnan Sabir”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels